Abstract
Objective
To investigate the timing of pregnancy and pregnancy termination and its management in women with pregnancy complicating systemic lupus erythematosus (SLE).
Methods
A series of 86 cases of pregnancy complicating SLE treated in our hospital from January 2005 to June 2010 were retrospectively reviewed, including 54 cases of planned pregnancy and 32 cases of unplanned pregnancy. The pregnancy courses and clinical outcomes were analyzed.
Results
While 12 patients in planned pregnancy group showed active SLE during pregnancy, all 32 patients in the unplanned pregnancy group presented severe SLE complications. The incidences of pregnancy loss, preterm delivery and neonatal asphyxia in the unplanned pregnancy group were significantly higher than planned pregnancy group (P < 0.05), and the infant body weight was lower in the unplanned pregnancy group (P < 0.05). A total of 78 live infants were born and no mortality was reported, including 15 preterm infants and one neonatal SLE.
Conclusion
Planned pregnancy during stable stage, appropriate treatment in pregnancy and close monitoring can improve the security of pregnancy complicating SLE. In situations that the drug treatment is ineffective and the mother and infant are threatened, or the fetus is mature, the pregnancy should be terminated promptly, thereby reducing the complications, and increasing the success rate of pregnancy and perinatal survival rate.
Similar content being viewed by others
References
Cunningham FG, Gant NF, Leveno I et al (2002) Williams obstetrics, 21st edn. Appleton-Century-Crosfts, USA, pp 1385–1389
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725 [PubMed: 9324032]
Yasmeen S, Wilkins EE, Field NT et al (2001) Pregnancy outcomes in women with systemic lupus erythematosus. J Matern Fetal Med 10:91–96
Van Horn JT, Craven C, Ward K et al (2004) Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 25(7):642–648
Clowse ME, Magder LS, Witter F et al (2005) The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52(2):514–521
Moroni G, Ponticelli C (2005) Pregnancy after lupus nephritis. Lupus 14:89–94
Buyon JP, Clancy RM (2005) Neonatal lupus:basic research and clinical perspectives. Rheum Dis Clin North Am 31(2):299–313
Cortes-Hernandez J, Ordi-Ros J, Paredes F et al (2002) Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus:a prospective study of 103 pregnancies. Rheumatology 41(6):643–650
Urowitz MB, Glandman DD, Farwuell VT et al (1993) Lupus and pregnancy studies. Arthritis Rheum 36:1392–1397
Le Huong D, Wechsler B, Vauthier-Brouzes D et al (1997) Outcome of planned pregnancies in systemic lupus erythematosus; a prospectivestudy on 62 pregnancies. Br J Rheumatol 36:772–777
Sittiwangkul S, Louthrenoo W, Vithayasai P et al (1999) Pregnancy outcome in Thai patientswith systemic lupus erythematosus. Asian Pac J Allergy Immunol 17:77–83
Tncani A, Faden D, Taranttini M et al (1992) Systemic lupus erthematosus and pregnancy; a prospective study. Clin Exp Rheumatol 10:439–464
Costedoat-Chalumeau N, Amoura Z, Huong du LT et al (2005) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Autoimmun Rev 4(2):111–115
Levy RA, Vilela VS, Cataldo MJ et al (2001) Hydroxychloroquine (HCQ) in lupus pregnancy: double 2blind and placebo-controlled study. Lupus 10(6):401–404
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wei, Q., Ouyang, Y., Zeng, W. et al. Pregnancy complicating systemic lupus erythematosus: a series of 86 cases. Arch Gynecol Obstet 284, 1067–1071 (2011). https://doi.org/10.1007/s00404-010-1786-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-010-1786-5